Greenstone Llc
Complete recall history across all FDA and CPSC categories — 7 total recalls
Greenstone Llc appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (7)
FDA drug safety enforcement actions by Greenstone Llc
| Date | Product | Reason | Class |
|---|---|---|---|
| Jan 15, 2026 | methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton cont... | Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil... | Class II |
| Mar 6, 2014 | Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottl... | Presence of Foreign Tablets/Capsules: report of a foreign capsule with markin... | Class I |
| Nov 5, 2013 | sertraline HCl tablets, 25 mg, 30 Tablets, Rx only, GREENSTONE BRAND --- Dist... | Labeling: Incorrect or Missing Lot No. and/or Exp Date: Expiration date incor... | Class II |
| Nov 4, 2013 | Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, ... | Failed Dissolution Specification; the bulk lot yielded an out of specificatio... | Class III |
| Nov 1, 2013 | Nifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, ... | Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalli... | Class II |
| Sep 4, 2013 | Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By:... | Marketed without an Approved NDA/ANDA: This recall is being initiated because... | Class II |
| Sep 4, 2013 | Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By:... | Marketed without an Approved NDA/ANDA: This recall is being initiated because... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.